Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway

Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen:
https://doi.org/10.48693/293
Open Access logo originally created by the Public Library of Science (PLoS)
Langanzeige der Metadaten
DC ElementWertSprache
dc.creatorSokoya, Tolulope-
dc.creatorParolek, Jan-
dc.creatorFoged, Mads Møller-
dc.creatorDanylchuk, Dmytro I.-
dc.creatorBozan, Manuel-
dc.creatorSarkar, Bingshati-
dc.creatorHilderink, Angelika-
dc.creatorPhilippi, Michael-
dc.creatorBotto, Lorenzo D.-
dc.creatorTerhal, Paulien A.-
dc.creatorMäkitie, Outi-
dc.creatorPiehler, Jacob-
dc.creatorKim, Yeongho-
dc.creatorBurd, Christopher G.-
dc.creatorKlymchenko, Andrey S.-
dc.creatorMaeda, Kenji-
dc.creatorHolthuis, Joost C. M.-
dc.date.accessioned2023-04-19T07:57:51Z-
dc.date.available2023-04-19T07:57:51Z-
dc.date.issued2022-09-14-
dc.identifier.citationTolulope Sokoya, Jan Parolek, Mads Møller Foged, Dmytro I Danylchuk, Manuel Bozan, Bingshati Sarkar, Angelika Hilderink, Michael Philippi, Lorenzo D Botto, Paulien A Terhal, Outi Mäkitie, Jacob Piehler, Yeongho Kim, Christopher G Burd, Andrey S Klymchenko, Kenji Maeda, Joost CM Holthuis (2022) Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway eLife 11:e79278ger
dc.identifier.urihttps://doi.org/10.48693/293-
dc.identifier.urihttps://osnadocs.ub.uni-osnabrueck.de/handle/ds-202304198687-
dc.description.abstractSphingomyelin is a dominant sphingolipid in mammalian cells. Its production in the trans-Golgi traps cholesterol synthesized in the ER to promote formation of a sphingomyelin/sterol gradient along the secretory pathway. This gradient marks a fundamental transition in physical membrane properties that help specify organelle identify and function. We previously identified mutations in sphingomyelin synthase SMS2 that cause osteoporosis and skeletal dysplasia. Here, we show that SMS2 variants linked to the most severe bone phenotypes retain full enzymatic activity but fail to leave the ER owing to a defective autonomous ER export signal. Cells harboring pathogenic SMS2 variants accumulate sphingomyelin in the ER and display a disrupted transbilayer sphingomyelin asymmetry. These aberrant sphingomyelin distributions also occur in patient-derived fibroblasts and are accompanied by imbalances in cholesterol organization, glycerophospholipid profiles, and lipid order in the secretory pathway. We postulate that pathogenic SMS2 variants undermine the capacity of osteogenic cells to uphold nonrandom lipid distributions that are critical for their bone forming activity.eng
dc.relationhttps://doi.org/10.7554/eLife.79278ger
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectsphingolipidger
dc.subjectmammalian cellsger
dc.subjectSphingomyelin synthaseger
dc.subject.ddc570 - Biowissenschaften, Biologieger
dc.titlePathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathwayeng
dc.typeEinzelbeitrag in einer wissenschaftlichen Zeitschrift [Article]ger
orcid.creatorhttps://orcid.org/0000-0003-1831-8706-
orcid.creatorhttps://orcid.org/0000-0001-8912-1586-
orcid.creatorhttps://orcid.org/0000-0001-8426-369X-
orcid.creatorhttps://orcid.org/0000-0002-4547-001X-
orcid.creatorhttps://orcid.org/0000-0002-2143-2270-
orcid.creatorhttps://orcid.org/0000-0002-1477-925X-
dc.identifier.doi10.7554/eLife.79278-
Enthalten in den Sammlungen:FB05 - Hochschulschriften
Open-Access-Publikationsfonds

Dateien zu dieser Ressource:
Datei Beschreibung GrößeFormat 
Sokoya_etal_elife_2022.pdfArticle15,55 MBAdobe PDF
Sokoya_etal_elife_2022.pdf
Miniaturbild
Öffnen/Anzeigen


Diese Ressource wurde unter folgender Copyright-Bestimmung veröffentlicht: Lizenz von Creative Commons Creative Commons